Solid Biosciences Inc. — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2023-01-03

Reporting Person: Morris Carl Ashley (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-03	Employee Stock Option (Right to Buy)	$5.62	A	95110	Acquired	2033-01-03	Common Stock (95110)	Direct
2023-01-03	Restricted Stock Units	$	A	47555	Acquired		Common Stock (47555)	Direct

Footnotes

F1: This option was granted on January 3, 2023 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F3: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.